BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Longo M, Paolini E, Meroni M, Dongiovanni P. Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution. Biomedicines 2022;10:648. [DOI: 10.3390/biomedicines10030648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kizilaslan EZ, Ghadge NM, Martinez A, Bass M, Winayak R, Mathew M, Amin R, Khan M, Kizilbash N. Acute Intermittent Porphyria’s Symptoms and Management: A Narrative Review. Cureus 2023. [DOI: 10.7759/cureus.36058] [Reference Citation Analysis]
2 Menezes PR, Trufen CEM, Lichtenstein F, Pellegrina DVDS, Reis EM, Onuki J. Transcriptome profile analysis reveals putative molecular mechanisms of 5-aminolevulinic acid toxicity. Arch Biochem Biophys 2023;738:109540. [PMID: 36746260 DOI: 10.1016/j.abb.2023.109540] [Reference Citation Analysis]
3 Scollan ME, Lauren CT. Photodermatoses: what's new. Curr Opin Pediatr 2022;34:374-80. [PMID: 35836395 DOI: 10.1097/MOP.0000000000001155] [Reference Citation Analysis]